Table 1 Characteristics of the sample (n = 430 patients)
Variable | Level | N = 430 | % |
|---|---|---|---|
Gender | Male | 332 | 77.2 |
Female | 98 | 22.8 | |
Age (years) | Median | 69 | – |
Std Dev | 10.04 | – | |
BMI (kg/m2) | Median | 27.85 | – |
Std Dev | 5.27 | – | |
Race | White | 404 | 94.0 |
Black | 14 | 3.3 | |
Asian | 1 | 0.2 | |
Native Hawaiian/Pacific Islander | 1 | 0.2 | |
American Indian/Alaskan | 1 | 0.2 | |
Unknown/Other | 9 | 2.1 | |
ASA score | 1 | 3 | 0.7 |
2 | 194 | 45.1 | |
3 | 224 | 52.1 | |
4 | 9 | 2.1 | |
Anesthesia groups | General only | 215 | 50.0 |
General + Epidural | 215 | 50.0 | |
Neoadjuvant chemotherapy | No | 305 | 71.4 |
Yes | 122 | 28.6 | |
Unknown | 3 | – | |
Diversion Type | Ileal conduit | 280 | 65.1 |
Continent catherizable pouch | 15 | 3.5 | |
Neobladder | 67 | 15.6 | |
Cutaneous ureterostomy | 63 | 14.6 | |
pT stage | T0 | 59 | 13.7 |
T1 | 44 | 10.2 | |
T2 | 82 | 19.1 | |
T3 | 125 | 29.1 | |
T4 | 62 | 14.4 | |
Ta/Tis | 58 | 13.5 | |
pN stage | Nx | 19 | 4.4 |
N1 | 35 | 8.1 | |
N2 | 60 | 14.0 | |
N3 | 17 | 4.0 | |
N0 | 299 | 69.5 | |
Radial margin | Negative | 377 | 87.7 |
Positive | 53 | 12.3 | |
Ureteral or urethral margin | Negative | 402 | 93.5 |
Positive | 28 | 6.5 | |
Grade | High | 350 | 96.7 |
Low | 5 | 1.4 | |
Mixed | 2 | 0.6 | |
Missing | 73 | – | |
Adjuvant chemotherapy | No | 340 | 79.8 |
Yes | 86 | 20.2 | |
Missing | 4 | – | |
Location of Recurrence | Pelvic | 22 | 16.5 |
Upper tract | 11 | 8.3 | |
Distant | 97 | 72.9 | |
Other | 3 | 2.3 | |
None | 297 | – |